Forte Biosciences, INC. (FBRX) — DEF 14A Filings
All DEF 14A filings from Forte Biosciences, INC.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Forte Biosciences Files 2025 DEF 14A
— Apr 30, 2025 Risk: low
Forte Biosciences, Inc. filed a DEF 14A on April 30, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other cor -
Forte Biosciences Files Definitive Proxy Statement
— Dec 31, 2024 Risk: low
Forte Biosciences, Inc. filed its definitive proxy statement on December 31, 2024, for the fiscal year ending December 31, 2024. The filing, designated as DEF 1 -
Forte Biosciences Files Definitive Proxy Statement
— Jul 30, 2024 Risk: low
Forte Biosciences, Inc. filed its definitive proxy statement (DEF 14A) on July 30, 2024, for its annual meeting on August 20, 2024. The filing concerns the soli
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX